UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A

Thrombosis research, 2019-11, Vol.183, p.1-3

2019

Volltextzugriff (PDF)

Updates on Novel Non-Replacement Drugs for Hemophilia

Pharmaceuticals (Basel, Switzerland), 2022-09, Vol.15 (10), p.1183

2022

Volltextzugriff (PDF)

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia

Journal of clinical medicine, 2023-10, Vol.12 (20), p.6672

2023

Volltextzugriff (PDF)

Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect

Vaccines (Basel), 2024-07, Vol.12 (7), p.709

2024

Volltextzugriff (PDF)

Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients

Medicina (Kaunas, Lithuania), 2024-01, Vol.60 (1), p.34

2024

Volltextzugriff (PDF)

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

Journal of clinical medicine, 2022-04, Vol.11 (7), p.1969

2022

Volltextzugriff (PDF)

Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives

Journal of blood medicine, 2022-01, Vol.13, p.191-199

Pasca, Samantha

2022

Volltextzugriff (PDF)

Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

Journal of clinical medicine, 2022-06, Vol.11 (12), p.3434

2022

Volltextzugriff (PDF)

Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion

Clinical and applied thrombosis/hemostasis, 2015-05, Vol.21 (4), p.373-377

2015

Volltextzugriff (PDF)

Specific serum biomarkers to assess the bone health in a group of hemophilia A carriers: Data from the CAR.BONE study

Thrombosis research, 2024-01, Vol.233, p.200-202

2024

Volltextzugriff (PDF)

Prothrombin Complex Concentrate Such as Therapy and Prophylaxis in Factor X-Deficient Patient (Friuli Variant)

Clinical and applied thrombosis/hemostasis, 2011-08, Vol.17 (4), p.332-336

2011

Volltextzugriff (PDF)

PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A

Thrombosis research, 2017-09, Vol.157, p.58-63

2017

Volltextzugriff (PDF)

Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry

Thrombosis research, 2023-01, Vol.221, p.35-36

2023

Volltextzugriff (PDF)

Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review

Drug design, development and therapy, 2022-01, Vol.16, p.3109-3116

2022

Volltextzugriff (PDF)

Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: the history of a success

Blood coagulation & fibrinolysis, 2018-07, Vol.29 (5), p.465-468

2018

Volltextzugriff (PDF)

Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®)

Thrombosis research, 2020-11, Vol.195, p.125-127

2020

Volltextzugriff (PDF)

Can the plasmaderived factor VIII still play a role in the treatment of acquired hemophilia A at the time of new drugs?

Blood coagulation & fibrinolysis, 2018-07, Vol.29 (5), p.417-422

2018

Volltextzugriff (PDF)

pdFVIII/VWF may be an alternative treatment for old medical patient with acquired haemophilia A and systemic vascular disease?

Transfusion and apheresis science, 2013-02, Vol.48 (1), p.59-62

2013

Volltextzugriff (PDF)

Safety and efficacy of thromboprophylaxis with fondaparinux in elderly acutely ill medical patients with renal impairment: a retrospective single center study

Italian journal of medicine, 2013-01, Vol.7 (4), p.287-292

2013

Volltextzugriff (PDF)

Direct Oral Anticoagulants for Very Elderly People With Atrial Fibrillation: Efficacy and Safe Enough?

Clinical and applied thrombosis/hemostasis, 2017-01, Vol.23 (1), p.58-63

2017

Volltextzugriff (PDF)

ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers

Seminars in thrombosis and hemostasis, 2021-02, Vol.47 (1), p.84-89

2021

Volltextzugriff (PDF)

Direct Oral Anticoagulants for Very Elderly People With Atrial Fibrillation

Clinical and applied thrombosis/hemostasis, 2017-01, Vol.23 (1), p.58-63

2017

Volltextzugriff (PDF)

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

BJOG : an international journal of obstetrics and gynaecology, 2012-11, Vol.119 (12), p.1529-1537

2012

Volltextzugriff (PDF)

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

PloS one, 2015-05, Vol.10 (5), p.e0124719-e0124719

2015

Volltextzugriff (PDF)

Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion: A Case–Control Study

Clinical and applied thrombosis/hemostasis, 2015-05, Vol.21 (4), p.373-377

2015

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

9 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A

Updates on Novel Non-Replacement Drugs for Hemophilia

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia

Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect

Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives

Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion

Specific serum biomarkers to assess the bone health in a group of hemophilia A carriers: Data from the CAR.BONE study

Prothrombin Complex Concentrate Such as Therapy and Prophylaxis in Factor X-Deficient Patient (Friuli Variant)

PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A

Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry

Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review

Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: the history of a success

Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®)

Can the plasmaderived factor VIII still play a role in the treatment of acquired hemophilia A at the time of new drugs?

pdFVIII/VWF may be an alternative treatment for old medical patient with acquired haemophilia A and systemic vascular disease?

Safety and efficacy of thromboprophylaxis with fondaparinux in elderly acutely ill medical patients with renal impairment: a retrospective single center study

Direct Oral Anticoagulants for Very Elderly People With Atrial Fibrillation: Efficacy and Safe Enough?

ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers

Direct Oral Anticoagulants for Very Elderly People With Atrial Fibrillation

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion: A Case–Control Study

Aktive Filter

Suchergebnisse filtern